Indaptus Therapeutics, Inc.
INDPNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $366.97M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.92$5.96
- Volume (live)
- -
- Avg. volume (3M)
- 651.27K
Indaptus Therapeutics (INDP) Stock Price & Financial Analysis
Indaptus Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.86 - $3.22 |
|---|---|
| 52-Week High | $5.96 |
| 52-Week Low | $0.92 |
| Open | $3.00 |
| Volume (last close) | 287.48K |
| Average Volume (3M) | 651.27K |
| 50-Day MA | $2.20 |
|---|---|
| 200-Day MA | $2.28 |
| 1-Year Change | −15.77% |
| Market Cap | 366.97M |
|---|---|
| Shares Outstanding | 116.13M |
| Price to Book (P/B) | 32.27 |
| EV/EBITDA | -21.94 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Indaptus Therapeutics at a Glance
As of the Oct 23, 2026 close, Indaptus Therapeutics (INDP) has a market capitalization of $366.97M.
As of its latest reported balance sheet, it holds $7.55M in cash and securities against $0.00 of debt, a net cash position of $7.55M.
Indaptus Therapeutics does not currently pay a dividend.
The share price is down 15.8% over the past year. At $3.16 (the Oct 23, 2026 close) it sits within its 52-week range of $0.92 to $5.96, above its 200-day moving average of $2.28.
Frequently Asked Questions About Indaptus Therapeutics
What is the current stock price for INDP?
As of the Oct 23, 2026 close, INDP stock trades at $3.16. The 52-week range is $0.92–$5.96, with a day range of $2.86–$3.22.
What is the P/E ratio for INDP?
The P/E ratio (Price-to-Earnings) for INDP is shown in the Key Statistics section. This valuation metric helps compare Indaptus Therapeutics, Inc. to industry peers.
Does INDP pay dividends?
Indaptus Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INDP?
Analyst ratings and recommendations for INDP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INDP?
As of the Oct 23, 2026 close, Indaptus Therapeutics's market capitalization is $367.0M, classifying it as a small-cap company. Indaptus Therapeutics operates in the Healthcare sector within the Biotechnology industry.